Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction: A meta-analysis of randomized clinical trials

Journal of the American College of Cardiology

Volumn 33, Issue 3, 1999, Pages 598-604

  Domanski, Michael J ^a   Exner, Derek V ^a   Borkowf, Craig B ^a   Geller, Nancy L ^a   Rosenberg, Yves ^a   Pfeffer, Marc A ^b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; RAMIPRIL; TRANDOLAPRIL; ZOFENOPRIL;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; PROTEINASE INHIBITION; RANDOMIZED CONTROLLED TRIAL; SUDDEN DEATH; TREATMENT OUTCOME;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DEATH, SUDDEN, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PEPTIDYL-DIPEPTIDASE A; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0033101663     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00609-3     Document Type: Article

References (57)

1. Kannel W., Sorlie P., McNamara P. Prognosis after initial myocardial infarction the Framingham study . Am J Cardiol. 44:1979;53-59.
2. White H.D., Norris R.M., Brown M.A., Brandt P.W., Whitlock R.M., Wild C.J. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 76:1987;44-51.
3. Hammermeister K., DeRouen T., Dodge H. Variables predictive of survival in patients with coronary disease selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic and quantitative angiographic evaluations . Circulation. 59:1979;421-430.
4. Pfeffer M., Braunwald E. Ventricular remodeling after myocardial infarction experimental observations and clinical implications . Circulation. 81:1990;1161-1172.
5. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction results of the Survival and Ventricular Enlargement Trial . N Engl J Med. 327:1992;669-677.
6. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 333:1995;1670-1676.
7. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 3:1993;821-828.
8. ISIS-4 a randomized trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet. 345:1995;669-685.
9. GISSI-3 effects of lisinopril and transdermal glycerol trinitrate singly and together on 6 week mortality and ventricular function after acute myocardial infarction . Lancet. 343:1994;1115-1122.
10. Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction interim report from the Chinese Cardiac Study (CCS-1) . Lancet. 345:1995;686-687.
11. Puri S., Cleland J. How do ACE inhibitors reduce mortality in patients with left ventricular dysfunction with and without heart failure? Br Heart J. 72:1994;81-86.
12. Yusuf S., Pepine C., Garces C., Poleur H., Salem D., Kostis J., et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fraction. Lancet. 340:1992;1173-1178.
13. Lyons D., Roy S., O'Byrne S., Swift C. ACE inhibition. Postsynaptic adrenergic sympatholytic action in men. Circulation. 96:1997;911-915.
14. N Engl J Med. 332:1995;80-85.
15. N Engl J Med. 327:1992;678-684.
16. Cleland J.G., Erhardt L., Murray G., Hall A.S., Ball S.G. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators. Eur Heart J. 18:1997;41-51.
17. Nabel E., Topol E., Galeana A., et al. A randomized placebo-controlled trial of early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction. J Am Coll Card. 17:1991;467-473.
18. Kleber F., Sabin G., Winter U., et al. Angiotensin-converting enzyme inhibitors in preventing remodeling and development of heart failure after acute myocardial infarction results of the German multicenter study of the effects of captopril on cardiopulmonary exercise parameters (ECCE) . Am J Cardiol. 80:1997;162A-167A.
19. Foy S., Crozier I., Turner J., et al. Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction. (the PRACTICAL Study). Am J Cardiol. 1994;1180-1186.
20. Early treatment with low-dose enalapril after acute myocardial infarction An equilibrium radionuclide angiographic study . J Nuc Cardiol. 4:1997;133-139.
21. Søgaard P., Gotzsche C., Ravkilde J., Thygesen K. Effects of Captopril on ischemia and dysfunction of the left ventricle after myocardial infarction. Circulation. 87:1993;1093-1099.
22. Acute intervention with captopril during thrombolysis in patients with first anterior myocardial infarction. Results from the Captopril and Thrombolysis Study. Eur Heart J. 15:1994;898-907.
23. Effects of enalapril on left ventricular function and exercise performance after a first acute myocardial infarction. Int J Cardiol. 59:1997;257-265.
24. Oldroyd K., Pye M., Ray S., et al. Effects of early captopril administration on infarct expansion, left ventricular remodeling and exercise capacity after acute myocardial infarction. Am J Cardiol. 68:1991;713-718.
25. Sharpe N., Smith H., Murphy J., Greaves S., Hart H., Gamble G. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition. Lancet. 337:1991;872-876.
26. Mortarino G., Ghiringhelli M., Onofri M., Trudu A., Corda G. Mechanocardiographic effects of ACE-inhibitors. Acta Cardiologica. XIV:1990;537-546.
27. Agresti A. Categorical Data Analysis. 1990;John Wiley and Sons, New York.
28. Geller N., Proschan M. Meta-analysis of clinical trials a consumer's guide . J Biopharm Stat. 6:1990;377-394.
29. Schulman S., Weiss J., Becker L., Guerci A., Shapiro E., Chandra N., Siu C., Flaherty J., Coombs V., Taube J., Bahr R., McVeigh E., Weisman H., Weisfeldt M., Gertstenblith G. Effect of early enalapril therapy on left ventricular function and structure in acute myocardial infarction. Am J Cardiol. 1995;764-770.
30. Kontopoulos A.G., Athyros V.G., Papageorgiou A.A., Papadopoulos G.V., Avramidis M.J., Boudoulas H. Effect of quinapril or metoprolol on heart rate variability in post-myocardial infarction patients. Am J Cardiol. 77:1996;242-246.
31. Bonaduce D., Marciano F., Petretta M., et al. Effect of converting enzyme inhibition on heart period variability in patients with acute myocardial infarction. Circulation. 90:1994;108-113.
32. Pfeffer M., Greaves S., Arnold J., Glynn R., LaMotte F., Lee R., Menapace F., Rappaport E., Ridker P., Rouleau J., Solomon S., Hennekens C. Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial. Circulation. 95:1997;2643-2651.
33. Sigurdsson A., Held P., Anderson G., Swedburg K. Enalaprilat in acute myocardial infarction tolerability and effects on the renin angiotensin system . Int J Card. 3:1991;115-124.
34. Bussmann W., Micke G., Hildenbrand R., Klepzig H. Captopril in acute myocardial infarction beneficial effects on infarct size and arrhythmias . Clin Cardiol. 18:1995;465-470.
35. Pfeffer M., Lamas G., Vaughan D., Parsi A., Braunwald E. Effect of captopril on progressive ventricular dilation after anterior myocardial infarction. N Engl J Med. 319:1988;80-86.
36. Barr C., Naas A., Fenwick M., Struthers A. Enalapril reduces QTc dispersion in mild congestive heart failure secondary to coronary artery disease. Am J Cardiol. 79:1997;328-333.
37. Kleber F., Reindl I., Wenzel M. Experiences with ACE inhibitors early after acute myocardial infarction. Rationale and design of the German multicenter study on the effects of captopril on cardiopulmonary exercise parameters post myocardial infarction (ECCE). Herz. 18:1993;424-429.
38. DiPasquale P., Paterna S., Cannizzaro S., et al. Captopril and glutathione before thrombolysis in acute myocardial infarction a pilot study . Drugs Exptl Clin Res. XVIII:1992;401-406.
39. Johnson D., Foster R., Barilla F., Blackwell G., Rodney M., Stanley A., Kirk K., Orr R., Geest R., Reiber J., Dell'Italia L. Angiotensin converting enzyme inhibitor therapy affects left ventricular mass in patients with ejection fraction >40% after acute myocardial infarction. J Am Coll Cardiol. 29:1997;49-54.
40. Shen W., Li M., Gong L. Beneficial effects of captopril on prognosis in patients with acute myocardial infarction. Chinese Med J. 109:1996;588-591.
41. Grassi G., Cattaneo B.M., Seravalle G., Lanfranchi A., Pozzi M., Morganti A., Carugo S., Mancia G. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation. 96:1997;1173-1179.
42. McKenna W., Haywood G. The role of ACE inhibitors in the treatment of arrhythmias. Clin Cardiol. 13:1990;VII49-VII52.
43. Ebert T. Captopril potentiates chronotropic baroreflex responses to carotid stimuli in humans. Hypertension. 7:1985;602-606.
44. Lancet. 351:1998;478-484.
45. Siscovick D., Ragahunathan T., Psaty B., et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med. 330:1994;1852-1857.
46. Weisman H., Bush D., Mannisi J., Weisfeldt M., Healy B. Cellular mechanisms of myocardial infarct expansion. Circulation. 78:1988;106-201.
47. Weber K., Brilla C., Janicki J. Myocardial fibrosis functional significance and regulatory factors . Cardiovasc Res. 27:1993;341-348.
48. Anversa P., Beghi C., Kikkawa Y., Olivetti G. Myocardial infarction in rats infarct size, myocyte hypertrophy and capillary growth . Circ Res. 58:1986;26-67.
49. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. Circulation. 87:1993;17-23.
50. Left ventricular dilatation and high grade ventricular arrhythmias in the first year after myocardial infarction. J Card Failure. 1:1994;3-11.
51. Pognizd S. Focal mechanisms underlying ventricular tachycardia during prolonged ischemic cardiomyopathy. Circulation. 90:1994;1441-1458.
52. Søgaard P., Thygesen K. Potential proischemic effect of early enalapril in hypotension-prone patients with acute myocardial infarction. The CONSENSUS II Holter substudy group. Cardiology. 88:1997;285-291.
53. Konstam M., Rosseau M., Kronenberg M., et al. Effects of the angiotensin converting enzyme inhibitor enalapril on the long term progression of left ventricular dysfunction in patients with heart failure. Circulation. 86:1992;431-438.
54. Kingma J.H., de Graeff P.A., van Gilst W.H., van Binsbergen E., de Langen C.D., Wesseling H. Effects of intravenous captopril on inducible sustained ventricular tachycardia one week after experimental infarction in the anaesthetized pig. Postgrad Med J. 62:1986;159-163.
55. Davies M., Thomas A. Thrombosis and acute coronary artery lesions in sudden cardiac ischemic death. N Engl J Med. 310:1984;1137-1140.
56. Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The Healing and Early Afterload Reducing Therapy Trial. Circulation. 95:1997;2643-2651.
57. Causes of early in-hospital mortality of patients with acute myocardial infarction the impact of ACE-inhibitor treatment . [abstract] Circulation. 92:1995;I673.